Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
downgraded at Citigroup from Buy to Hold, Citigroup said. Valuation call, based on a $43 price target.
upgraded at BMO from Market Perform to Outperform, BMO Capital said. $90 price target. Estimates also boosted.
Chimera Investment Corp
initiated at Barclays with an Overweight rating and $5 price target. A pure-play non-Agency mortgage REIT, fair value of the company's MBS continues to rise, Barclays said.
rated new Market Perform at Wells. Company has limited sales growth potential.
rated new Market Perform at Wells. Company could be hurt by rising input costs.
downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call.
downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Potential Afrezza approval has been pushed out.
upgraded at Citigroup from Sell to Hold, Citigroup said. $44 price target. Stock is already pricing in Aerospace and Fluid Handling problems.
rated new Buy at Collins Stewart. $80 price target. Company has solid near-term growth prospects.
Hudson City Bancorp
downgraded at Barclays to Equal Weight from Overweight after the company released earnings that showed weakening fundamentals and foreshadowed a potential dividend cut, Barclays said. Price target cut by a dollar to $13.
Hudson City Bancorp
downgraded at FBR from Market Perform to Underperform, FBR Capital Markets said. $10.50 price target. Earnings are falling, relative to peers.
upgraded at Citigroup from Hold to Buy, Citigroup said. $85 price target. Estimates also boosted, to match the company's new guidance.
downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call, based on a $59 price target.
upgraded at UBS from Neutral to Buy, UBS said. $12 price target. Estimates also boosted, given an improving DRAM market.
downgraded at William Blair from Outperform to Market Perform, William Blair said. Company is likely to post inconsistent results in the coming quarters.
downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Company faces increased regulatory risks.
Procter & Gamble
rated new Outperform at Wells Fargo. Company has an attractive opportunity to grow in its emerging markets.
downgraded at BMO from Outperform to Market Perform, BMO Capital said. $19 price target. Company will likely see lower sales growth.
downgraded at Piper to Neutral, Piper Jaffray said. Valuation call, based on a $29 price target.
initiated at Credit Suisse with an Underperform rating and $80 price target. Raw materials and end markets paint a difficult picture, Credit Suisse said.
downgraded at Janney to Neutral. $48 price target. Company faces cost headwinds.
downgraded at Citigroup from Buy to Hold, Citigroup said. Valuation call, based on a $49 price target.
rated new Neutral at Collins Stewart. Valuation call, based on a $92 price target.
downgraded at Piper to Underweight. Company faces multiple headwinds to growth in 2011.
This article was written by a staff member of TheStreet.